Penumbra is a healthcare company. Co.'s team focuses on developing, manufacturing and marketing medical devices. Co.'s neuro products include Penumbra System brand of products that provides a form of mechanical thrombectomy used by physicians to revascularize blood vessels that are blocked by clots in the intracranial vasculature. Co.'s vascular products include the Ruby Coil System that consists of detachable coils and is used in clinical applications such as active extravasations, or the escape of blood into surrounding tissue, selective embolization in patients with visceral aneurysms, embolization in patients with gastrointestinal bleeding, and high flow arterial venous malformations. The PEN stock yearly return is shown above.
The yearly return on the PEN stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2020 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the PEN annual return calculation with any dividends reinvested as applicable (on ex-dates).
|